Determinants of physical fitness in males with systolic heart failure

Kardiologia Polska

Volumn 68, Issue 2, 2010, Pages 146-154

  Wȩgrzynowska Teodorczyk, Kinga ^a   Rudzińska, Eliza ^a,b   Jankowska, Ewa ^b   Grzesło, Agnieszka ^b   Nowakowska, Katarzyna ^b   Łazorczyk, Małgorzata ^b   Banasiak, Waldemar ^b   Ponikowski, Piotr ^b   Woźniewski, Marek ^a  

^a UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

^b MILITARY HOSPITAL   (Poland)

Author keywords

Heart failure; Physical fitness; Severity of disease

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN;

ADULT; AGE; AGED; AGILITY; ARTICLE; COMORBIDITY; DIABETES MELLITUS; DISEASE COURSE; ENDURANCE; EXERCISE TOLERANCE; FITNESS; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; SYSTEMIC DISEASE; SYSTOLIC HEART FAILURE;

EID: 77950456320     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Buchman AS, Boyle PA, Wilson RS, et al. Physical activity and motor decline in older persons. Muscle Nerve 2007; 35: 254-262
2. Nessler J, Skrzypek A. Przewlekła niewydolność serca u osób w podeszłym wieku - aktualny problem medyczny. Pol Arch Med Wewn 2008; 118: 572-580
3. Muller F, Dehail P, Bestaven E, et al. Maximal and sustained isokinetic lower-limb muscle strength in hospitalized older people. Muscle Nerve 2007; 35: 739-744
4. Shumway CA, Guralink JM, Philips CL, et al. Age - associated declines in complex walking task performance: the Walking in Chianti toolkit. J Am Geriatr Soc 2007; 55: 58-65.
5. Swedberg K, Cleland J, Dargie H, et al. Diagnostyka i leczenie przewlekłej niewydolności serca. Wytyczne postȩpowania Europejskiego Towarzystwa Kardiologicznego. Kardiol Pol 2005; 63: 510-538
6. Cleland JG, Swedberg K, Follath F, et al. Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology2E The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003; 24: 442-463
7. Coats AJS, Clark AL, Piepoli M. Symptoms and quality of life in heart failure. Br Heart J 1994; 72: 36-39
8. Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113: 671-678
9. Holper EM, Brooks MM, Kim LJ, et al. Effects of heart failure and diabetes mellitus on long-term mortality after coronary revascularization (from the BARI Trial). Am J Cardiol 2007; 15: 196-202.
10. Uriata A, Zamora E, Lupon J, et al. Clinical, echocardiographic and prognostic evaluation of atrial fibrillation in patients with heart failure. Mad Clin (Barc) 2007; 129: 321-325
11. Faggiano P, D'Aloia A, Gualeni A, et al. The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature. Eur J Heart Fail 2004; 6: 687-691
12. Krauze-Wielicka M, Kasperczyk S, Przywara B, et al. Przydatnoś ć 6-minutowego testu spacerowego w ocenie zmian w stanie klinicznym chorych z niewydolnościa̧ serca podczas 6-miesiȩcznej obserwacji. Wiad Lek 2005; 58: 280-283
13. Pawłowska-Jenerowicz W, Serwacka M, Da̧browski M. Test spiroergometryczny - systematyczny wzrost popularności badania w obliczu zagrożenia epidemia̧ niewydolności serca. Folia Cardiol 2003; 10: 727-731
14. Working Group on Cardiac Rehabilitation and Exercise Physiology and Working Group on Heart Failure of the European Society of Cardiology. Recommendations for exercise testing in chronic heart failure patients. Eur Heart J 2001; 22: 37-45.
15. Rikli RE, Jones CJ. Development and validation of functional fitness test for community residing older adults. J Aig Phys Act 1999; 7: 129-161
16. Różańska-Kirschke A, Kocur P, Wilk M, et al. Test Fullerton jako miernik sprawności fizycznej osób starszych. Reh Med 2006; 2: 15-19
17. Bemben MG, McCalip GA. Strength and power relationships as a function of age. J Strength Cond Res 1999; 13: 330-338
18. Gibbons WJ, Fruchter N, Sloan S, et al. Reference values for multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardoipulm Rehabil 2001; 21: 87-93.
19. Izquierdo M, Hakkinen K, Anton K, et al. Maximal strength and power, endurance performance, and serum hormones in middle-aged and elderly men. Med Sci Sports Exerc 2001; 22: 1577-1587
20. Sunnerhagen KS, Hedberg M, Henning GB, et al. Muscle performance in an urban population sample of 40-to 79-year-old men and women. Scand J Rehabil Med 2000; 32: 159-167
21. Wȩgrzynowska-Teodorczyk K, Da̧browska E, Łazorczyk M, et al. Sprawność fizyczna mȩżczyzn z niewydolnościa̧ serca w porównaniu ze zdrowymi równolatkami. Fizjoterapia 2007; 15: 44-53.
22. Bittner V. Determining prognosis in congestive heart failure: role of the 6-minute walk test. Am Heart J 1999; 138: 593-596
23. Opasich C, Pinna GD, Mazza A, et al. Six-minute walking performance in patients with moderate - to severe heart failure. Eur Heart J 2001; 22: 488-496
24. Izawa KP, Watanabe S, Asada N, et al. Handgripstrength as a predictor of prognosis in Japanese patients with congestive heart failure. Eur J Cardiovasc Prev Rehabil 2009; 16: 21-27
25. Williams SG, Ng LL, O'Brien RJ, et al. Complementary roles of simple variables, NYHA and N-BNP, in indicating aerobic capacity and severity of heart failure. Int J Cardiol 2005; 10: 279-286
26. Koc M, Bozkurt A, Yildiray-Sahin D, et al. Cutoff values of NT-proBNP for the prediction of low functional capacity decreased ejection fraction and cardiovascular events in patients with heart failure. Cardiol J 2009; 16: 43-49
27. Pu CT, Johnson MT, Forman DE, et al. Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. J Appl Physiol 2001; 90: 2341-2350
28. Conraads VM, Beckers P, Vaes J, et al. Combined endurance/resistance training reduces NT-porBNP levels in patients with chronic heart failure. Eur Heart J 2004; 25: 1797-1805
29. Butterfield JA, Faddy SC, Davidson P, et al. Exercise training in patients with stable chronic heart failure:- effects on thoracic impedance cardiography and B-type natriuretic peptide. J Cardiopulm Rehabil Prev 2008; 28: 33-37
30. Holland GJ, Tanaka K, Shigematsu R, et al. Flexibility and physical functions of older adults: a review. J Aging Phys Activity 2002; 10; 169-206.
31. Bouchard C. Genetics of fitness and physical performance. Human Kinetics Champaign, 1997.
32. Ingle L, Reddy P, Clartk AL, et al. Diabetes lowers six-minute walk test performance in heart failure. J Am Cardiol 2006; 47: 1909-1910
33. Pardaens K, Van Cleemput J, Vanhaecke J, et al. Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients. Heart 1997; 78: 564-568
34. Parthenakis FI, Patrianakos AP, Skalidis EI, et al. Atrial fibrillation is associated with increased neurohumoral activation and reduced exercise tolerance in patients with non-ischemic dilated cardiomyopathy. Int J Cardiol 2007; 118: 206-214
35. Tibb AS, Ennezat PV, Chen JA, et al. Diabetes lowers aerobic capacity in heart failure. J Am Coll Cardiol 2005; 46: 930-931
36. Upon J, Gonzalez B, Mas D, et al. Clinical, echocardiographic and prognostic evaluation of atrial fibrillation in patients with heart failure. Med Clin Barc 2007; 129: 321-325
37. Nowak Z. Badania czynnościowe w diagnostyce choroby niedokrwiennej serca. AWF Katowice 2002.
38. Coirault C, Hagege A, Chemla D, et al. Angiotensin-converting enzyme inhibitor therapy improves respiratory muscle strength in patients with heart failure. Chest 2001; 119:1755-1760
39. Onder G, Penninx BW, Balkrishnan R, et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet 2002; 359: 926-930
40. Onder G, Vedova CD, Pahor M. Effects of ACE inhibitors on skeletal muscle. Curr Pharm Des 2006; 12: 2057-2064